Search

everythinglearnresearchcommunity

for

Search:↓

Men with early balding showed higher levels of certain genes linked to hair loss and possibly prostate cancer.

Prostate cancer screening doesn't significantly reduce death rates and has risks like overdiagnosis and side effects.

Higher cholesterol levels increase aggressive prostate cancer risk.

Prostate cancer risk is not linked to blood testosterone levels.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Finasteride treats hair loss and reduces prostate cancer risk.

Hair loss at the top of the head is linked to prostate cancer, but other types of hair loss are not.

Early baldness increases prostate cancer risk, radiotherapy and surgery have similar second cancer rates, and ALA may reduce prostate cancer risk.

Gene variant linked to prostate cancer, hormone levels, and hair loss.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

E211 G>A gene linked to lower risk of severe prostate cancer and hair loss.

New curcumin analogues help fight prostate cancer by breaking down androgen receptors.

Estradiol and castration reduced prostate cancer development in rats when applied at early stages, but were ineffective after cancer was established.

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

Circadian rhythm disruption, chronic inflammation, hormones, metabolism, and genetics may increase prostate cancer risk.

Urban living may increase prostate cancer risk, while early sexual activity might reduce it.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

Different prostate cancer treatments have similar risks of secondary cancers and related mortality when considering patient age and smoking history.

Antioxidants can block the cancer-fighting effects of doxorubicin.

Incidental prostate cancer was found in 4.89% of patients undergoing surgery for benign prostatic hyperplasia.

A man developed male breast cancer after four years of finasteride treatment for an enlarged prostate.

More research and guidelines are needed for managing prostate cancer in people with high-risk genetic mutations.

Finasteride treats hair loss but may affect prostate cancer detection.

Diabetes may lower the risk of prostate cancer.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

Urban living may increase prostate cancer risk, while early sexual activity might reduce it.